Form 4: Perrigo EVP David Ball Receives RSU Grant

Perrigo Company plc executive David Ball was granted 26,339 restricted stock units vesting over three years.

Summary

• David Ball, EVP & CBDO of Perrigo Company plc, was granted 26,339 restricted stock units (RSUs) on May 13, 2026.
• Each RSU represents a contingent right to receive one ordinary share of Perrigo Company plc.
• The RSUs vest in three equal annual installments starting on May 13, 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding executive compensation with no immediate impact on company operations or financial health.

Positives

• The grant aligns executive compensation with long-term shareholder interests through a multi-year vesting schedule.

Negatives

• None identified.

Risks

• The value of the equity grant is subject to market fluctuations in Perrigo's share price.

Future Outlook

The RSUs will vest in three equal annual installments beginning May 13, 2027, contingent upon continued service.

Industry Context

StockSavvy.ai notes that equity grants to key executives are standard corporate governance practices intended to incentivize long-term performance and retention within the pharmaceutical and consumer health sectors.

Comparison to Industry Standards

• The use of three-year graded vesting for RSUs is consistent with standard executive compensation practices among large-cap pharmaceutical companies.
• The grant structure aligns with typical equity incentive plans seen at peers like Haleon or Kenvue.

Stakeholder Impact

• Shareholders may view the equity grant as a standard alignment of executive interests with company performance.

Next Steps

• Vesting of the first tranche of RSUs on May 13, 2027.

Key Dates

Keywords

Perrigo, PRGO, Form 4, Insider Trading, Executive Compensation, Restricted Stock Units